Quarterly report pursuant to Section 13 or 15(d)

FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - 2013 Private Placement (Details Textual)

v2.4.0.8
FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - 2013 Private Placement (Details Textual) (USD $)
2 Months Ended 1 Months Ended 2 Months Ended
Aug. 31, 2013
Aug. 31, 2013
Aegis Capital Corp [Member]
Aug. 31, 2013
Former preferred and common shareholders [Member]
Aug. 31, 2013
Private Placement [Member]
Aug. 31, 2013
Private Placement [Member]
Aegis Capital Corp [Member]
Aug. 31, 2013
Exercise Price One [Member]
Private Placement [Member]
Aegis Capital Corp [Member]
Aug. 31, 2013
Exercise Price Two [Member]
Private Placement [Member]
Aegis Capital Corp [Member]
Jul. 31, 2013
Herbert Conrad [Member]
Aug. 31, 2013
Herbert Conrad [Member]
Private Placement [Member]
Formation And Reverse Acquisition [Line Items]                  
Stock Issued During Period, Shares, New Issues     9,000,000 [1] 15,000,000 [2]       351,563 250,000
Warrants Issued For Purchase Of Common Stock   2,250,000 1,500,000 [1] 7,500,000 [2]   750,000 1,500,000 250,000 125,000
Investment Warrants, Exercise Price       $ 2.00   $ 2.00 $ 1.00    
Proceeds from Issuance or Sale of Equity       $ 15,000,000 $ 15,000,000       $ 250,000
Proceeds from Issuance of Common Stock       11,983,000          
Proceeds from Issuance of Warrants       3,017,000         20,000
Placement Agent Fees         1,500,000        
Non Accountable Expense Allowance         450,000        
Fair Value Of Warrants Issued       1,300,000          
Warrant Solicitation Fee Percentage         5.00%        
Aggregate Common Stock Holding Percentage     28.50% [1] 47.70% [2]          
Aggregate Common Stock Holding Percentage Including Additional Share Issuance       30.00%          
Payments of Stock Issuance Costs 2,400,000                
Placement Agent Cash Fees And Expenses 1,950,000                
External Legal Costs $ 425,000                
[1] Includes 500,000 warrants purchased my Mr. Conrad - see Warrant Private Placement section.
[2] From the 2013 Private Placement, and includes 1 unit purchased by Mr. Conrad for $ 250,000 at the full price paid by all third party investors.